The present invention provides dihydroorotate dehydrogenase inhibitors, methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorders wherein the inhibition of Dihydroorotate dehydrogenase is known to show beneficial effect.
本发明提供了二氢
乳酸脱氢酶抑制剂,其制备方法,包含它们的制药组合物以及治疗、预防和/或改善已知抑制二氢
乳酸脱氢酶具有有益作用的疾病或障碍的方法。